Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:44 pm Purchase | 13G | Cyclo Therapeutics Inc. CYTH | ARMISTICE CAPITAL LLC | 1,501,625 4.990% | 471,625 (+45.79%) | View |
| 2023-10-24 4:43 pm Purchase | 13D | Cyclo Therapeutics Inc. CYTH | Rafael Holdings Inc. RFL | 12,780,543 49.000% | 623,329 (+5.13%) | View |
| 2023-08-07 3:35 pm Purchase | 13D | Cyclo Therapeutics Inc. CYTH | Rafael Holdings Inc. RFL | 12,157,214 49.000% | 9,642,244 (+383.39%) | View |
| 2023-05-11 4:48 pm Purchase | 13D | Cyclo Therapeutics Inc. CYTH | Rafael Holdings Inc. RFL | 2,514,970 16.600% | 2,514,970 (New Position) | View |
| 2023-02-14 12:30 pm Unchanged | 13G | Cyclo Therapeutics Inc. CYTH | ARMISTICE CAPITAL LLC | 1,030,000 10.830% | 0 (Unchanged) | View |
| 2023-02-10 4:28 pm Purchase | 13G | Cyclo Therapeutics Inc. CYTH | ARMISTICE CAPITAL LLC | 1,030,000 10.800% | 814,674 (+378.34%) | View |
| 2021-02-11 6:25 pm Sale | 13G | Cyclo Therapeutics Inc. CYTH | HIRSCHMAN ORIN | 209,383 4.990% | -208,617 (-49.91%) | View |
| 2020-12-17 08:11 am Purchase | 13G | Cyclo Therapeutics Inc. CYTH | HIRSCHMAN ORIN | 418,000 9.900% | 418,000 (New Position) | View |
| 2020-12-10 7:48 pm Purchase | 13G | Cyclo Therapeutics Inc. CYTH | ARMISTICE CAPITAL LLC | 215,326 4.990% | 215,326 (New Position) | View |
| 2020-09-02 4:03 pm Purchase | 13D | Cyclo Therapeutics Inc. CYTH | NOVIT L.P. | 35,135,164 19.100% | 35,135,164 (New Position) | View |
| 2020-08-31 5:09 pm Purchase | 13G | Cyclo Therapeutics Inc. CYTH | ARMISTICE CAPITAL LLC | 28,861,787 16.000% | 16,811,787 (+139.52%) | View |
| 2020-02-14 3:36 pm Purchase | 13G | Cyclo Therapeutics Inc. CYTH | ARMISTICE CAPITAL LLC | 12,050,000 9.900% | 12,050,000 (New Position) | View |